Publications by authors named "Mohamed Elshafei"

Migraine is a chronic neurological disorder affecting approximately 14% of the global population. Beyond physical pain, migraines significantly impact individuals' quality of life, influencing education, employment, and income levels. Topiramate, a second-generation antiepileptic medication, has demonstrated notable efficacy in reducing the occurrence of chronic migraine.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore how specific genetic variations (CYP2C9*2, *3, VKORC1-1639 G>A, and CYP4F2*3) affect warfarin dosing in an Arab population and to compare the effectiveness of genetic versus clinical dosing algorithms during warfarin initiation.
  • Involving 130 Arab patients, the research involved calculating initial warfarin doses using a clinical algorithm and subsequently using genetic data to determine more accurate dosing after a month.
  • Results indicated that genetic variations significantly influenced the required warfarin dose, with genetic dosing algorithms providing more accurate dose estimates than clinical methods based on a lower median absolute error.
View Article and Find Full Text PDF

Different dosing strategies exist to initiate warfarin, most commonly fixed warfarin dosing (FWD), clinical warfarin dosing (CWD), and genetic-guided warfarin dosing (GWD). Landmark trials have shown GWD to be superior when compared to FWD in the EU-PACT trial or CWD in the GIFT trial. COAG trial did not show differences between GWD and CWD.

View Article and Find Full Text PDF

Optic neuritis is an inflammatory condition involving the optic nerve causing vision abnormalities ranging from decreased to complete vision loss. We present a 30 years old lady who suffered acute gradual reduced vision, which progressed to complete vision loss in her right eye the next day after receiving one dose of intravenous Metronidazole.

View Article and Find Full Text PDF

Introduction: oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of choice for most clinical risks for which they are indicated. However, residual uncertainty remains regarding their use in preventing stroke in patients with low bodyweight [< 60 kg or body mass index (BMI) < 18 kg/m]. We have carried out pooled systematic analyses of published studies to determine the efficacy and safety of these agents compared with warfarin in stroke prevention in patients with low bodyweight.

View Article and Find Full Text PDF

Introduction: Direct oral anticoagulant (DOAC) agents are established as the anticoagulation strategy of choice for a variety of clinical risks. Despite this, uncertainty still exists with regard to their efficacy and safety for the prevention of stroke and systemic embolism in some patient populations; most notably those with low body weight (LBW) (<60 kg or body mass index [BMI] <18 kg/m). Currently, there is a paucity of trial and non-trial data to support a prescriptive recommendation for their use in these patient cohorts.

View Article and Find Full Text PDF

Background And Aims: As part of the COVID-19 control strategy, a growing number of vaccine portfolios evolved and got fast-tracked through regulatory agencies, with a limited examination of their efficacy and safety in vulnerable populations, such as patients with chronic conditions and immunocompromised states. Patients with chronic liver disease (CLD), and cohorts post liver transplant (LT) in particular, were underrepresented in the determinant trials of vaccine development, hence the paucity of data on their efficacy and safety in published literature. This systematic review aims to examine the available evidence and ascertain the effectiveness and safety of Covid-19 vaccination in patients with CLD and those with LT.

View Article and Find Full Text PDF

Background: Despite significant improvements in both treatment and prevention strategies, as well as multiple commissioned reviews, there remains uncertainty regarding the survival benefit of repurposed drugs such as colchicine in patients with Coronavirus Disease 2019 (COVID-19) clinical syndrome.

Methods: In this umbrella review, we carried out a comprehensive search of PubMed, EMBASE, Cochrane Database of Systematic Reviews, Science Citation Index, and the Database of Abstracts of Reviews of Effectiveness between January 1, 2020 and January 31, 2023 for systematic reviews and meta-analyses evaluating the mortality-reducing benefits of colchicine in patients with COVID-19. This was to ascertain the exact relationship between colchicine exposure and mortality outcomes in these cohorts of patients.

View Article and Find Full Text PDF

Background: With an increasingly strained health system budgets, healthcare services need to continually demonstrate evidence of economic benefits. This study sought to evaluate the economic impact of interventions initiated by clinical pharmacists in an adult general tertiary hospital.

Methods: A retrospective review of clinical pharmacist interventions was carried out throughout follow-up durations in March 2018, July/August 2018, and January 2019 in Hamad General Hospital (HGH) at Hamad Medical Corporation (HMC) in Qatar.

View Article and Find Full Text PDF
Article Synopsis
  • - Warfarin, a blood thinner, is heavily processed by the enzyme CYP2C9, and using it alongside rifampin, which boosts CYP2C9 activity, requires careful monitoring and dosage changes due to variable responses in patients.
  • - A study from 2016 to 2022 at Hamad Medical Corporation identified 36 patients using both medications, finding that those with certain genetic variants of CYP2C9 and VKORC1 were more likely to respond effectively to warfarin.
  • - Patients with these beneficial genotypes had a lower pre-interaction warfarin dose and better anticoagulation control compared to those without, indicating that genetic factors play a crucial role in treatment responses when taking warfar
View Article and Find Full Text PDF

Background And Purpose: Uncertainty remains regarding the impact of enteric-coated aspirin (EC-ASA) on secondary prevention of ischemic stroke compared to plain aspirin (P-ASA). Hence, this study was designed to investigate the effect of EC formulation on ASA response via evaluating thromboxane B2 (TXB2) levels in patients with suspected or newly diagnosed stroke.

Methods: A prospective cohort study on suspected or newly diagnosed ischemic stroke patients who are aspirin-naive was conducted.

View Article and Find Full Text PDF

Nowadays, wearables-based Human Activity Recognition (HAR) systems represent a modern, robust, and lightweight solution to monitor athlete performance. However, user data variability is a problem that may hinder the performance of HAR systems, especially the cross-subject HAR models. Such a problem may have a lesser effect on the subject-specific model because it is a tailored model that serves a specific user; hence, data variability is usually low, and performance is often high.

View Article and Find Full Text PDF

The antiviral medication "favipiravir" should be considered as a possible cause of unexplained sinus bradycardia.

View Article and Find Full Text PDF
Article Synopsis
  • Colchicine has been recently repurposed as a potential treatment for COVID-19, focusing on its effects on patient mortality.
  • A systematic review and meta-analysis of nine studies involving 5,522 patients showed that colchicine significantly reduced mortality rates compared to controls (OR 0.35).
  • The results highlight a beneficial impact of colchicine for hospitalized COVID-19 patients, but further trials are necessary to confirm these findings.
View Article and Find Full Text PDF

Recent studies revealed a high prevalence of venous thromboembolism (VTE) events in coronavirus disease 2019 (COVID-19) patients, especially in those who are critically ill. Available studies report varying prevalence rates. Hence, the exact prevalence remains uncertain.

View Article and Find Full Text PDF

Unlabelled: Haemoptysis is the expectoration of blood originating from the respiratory tract and occurs secondary to infection, malignancy, bronchiectasis or vascular disease. Its severity varies from minimal blood-streaked sputum to life-threatening haemorrhage. Therefore, prompt evaluation of the cause of the haemoptysis and its severity, and timely management are crucial.

View Article and Find Full Text PDF

Nowadays, Human Activity Recognition (HAR) systems, which use wearables and smart systems, are a part of our daily life. Despite the abundance of literature in the area, little is known about the impact of muscle fatigue on these systems' performance. In this work, we use the biceps concentration curls exercise as an example of a HAR activity to observe the impact of fatigue impact on such systems.

View Article and Find Full Text PDF

Fatigue is a naturally occurring phenomenon during human activities, but it poses a bigger risk for injuries during physically demanding activities, such as gym activities and athletics. Several studies show that bicep muscle fatigue can lead to various injuries that may require up to 22 weeks of treatment. In this work, we adopt a wearable approach to detect biceps muscle fatigue during a bicep concentration curl exercise as an example of a gym activity.

View Article and Find Full Text PDF

Rationale: Metformin-associated lactic acidosis (MALA) is a rare adverse effect that has significant morbidity and mortality. MALA is a high anion gap (AG), nonosmolar acidosis. Associated osmolar-gap (OG) is rarely reported, so finding an OG may make the diagnosis of MALA challenging.

View Article and Find Full Text PDF

Background: Drug-induced liver injury (DILI) represents an increasing morbidity in the general population, but more so in the elderly cohort of patients. Despite this, the concept of its prevention through prospective analysis has largely remained unexamined. We evaluated the utility of recently validated adverse drug reactions (ADR) avoidability tool in a cohort of elderly patients with DILI.

View Article and Find Full Text PDF

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-COV2) infection is a recently emerged viral infection causing predominantly mild upper respiratory symptoms. However, in some instances, it might result in acute respiratory distress syndrome (ARDS) that poses a significant mortality risk. ARDS is postulated to be mediated by a surge of pro-inflammatory cytokines and chemokines, leading to a dysregulated hyper inflammatory response.

View Article and Find Full Text PDF